Joel Greenblatt fit · Magic Formula - ROIC alto + EV/EBIT barato
Is Sarepta Therapeutics,, Inc. Common Stock (SRPT) a Joel Greenblatt Stock?
Partial match — either cheap or high-quality, but not both.
41/100
DSeñales mixtas
1/5 criterios cumplidos
Los criterios de Joel Greenblatt, aplicados a SRPT
EBIT/EV yield ≥ 10%
clave2.7%
ROIC ≥ 25%
clave6.1%
EV/EBIT ≤ 12
37.2x
Gross margin ≥ 30%
76.3%
Cómo se valora SRPT en otras estrategias
Datos financieros en vivo
Cap. mercado
$1.77B
PER (TTM)
31.3x
ROIC (TTM)
-1.53%
Margen bruto
62.39%
Otros análisis Joel Greenblatt
Preguntas frecuentes
What is SRPT's Joel Greenblatt fit score?
SRPT scores 41/100 on our Joel Greenblatt fit engine — grade D. Partial match — either cheap or high-quality, but not both.
Does Joel Greenblatt actually own SRPT?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends SRPT.
How often is this score updated?
SRPT's Joel Greenblatt fit score is recomputed daily from the latest TTM financials.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Joel Greenblatt posea o recomiende SRPT personalmente.